Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Prosperity Bancshares, Inc. (PB) A Good Stock To Buy?

Page 1 of 2

The equity market returns were very disappointing in the third quarter, “thanks” to the slowdown of China’s economy and the weaker-than-expected U.S. economic data. It was not entirely clear whether the broader market sell-off made U.S. equity valuations undervalued, but it definitely made them more attractive. It is worth mentioning that Russell 2000 ETF (IWM) underperformed the broad-market S&P 500 ETF by more than 14 percentage points during the period of June 25, 2015 through October 30, 2015. This clearly points to the fact that most investors, including hedge fund firms and institutional investors, heavily cut their exposure to high-potential (but seemingly riskier) small-cap stocks during the bloody third quarter. So let’s take a glance at the smart money sentiment towards Prosperity Bancshares, Inc. (NYSE:PB) and see how it was affected.

Is Prosperity Bancshares, Inc. (NYSE:PB) worth your attention right now? The best stock pickers are selling. The number of bullish hedge fund positions retreated by 1 in recent months. Prosperity Bancshares, Inc. (NYSE:PB) was in 16 hedge funds’ portfolios at the end of September. There were 17 hedge funds in our database with Prosperity Bancshares, Inc. (NYSE:PB) holdings at the end of the previous quarter. At the end of this article, we will also compare Prosperity Bancshares, Inc. (NYSE:PB) to other stocks, including Youku Tudou Inc (ADR) (NYSE:YOKU), BIO-TECHNE Corp (NASDAQ:TECH), and GNC Holdings Inc (NYSE:GNC) to get a better sense of its popularity.

Follow Prosperity Bancshares Inc (NYSE:PB)
Trade (NYSE:PB) Now!

According to most shareholders, hedge funds are perceived as slow, old investment vehicles of years past. While there are more than 8000 funds in operation at present, We look at the crème de la crème of this group, approximately 700 funds. These investment experts orchestrate most of all hedge funds’ total asset base, and by following their finest equity investments, Insider Monkey has brought to light various investment strategies that have historically exceeded Mr. Market. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points a year for a decade in their back tests.

With all of this in mind, let’s take a gander at the recent action regarding Prosperity Bancshares, Inc. (NYSE:PB).

How are hedge funds trading Prosperity Bancshares, Inc. (NYSE:PB)?

Heading into Q4, a total of 16 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -6% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their holdings significantly (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Fisher Asset Management, managed by Ken Fisher, holds the largest position in Prosperity Bancshares, Inc. (NYSE:PB). Fisher Asset Management has a $37.1 million position in the stock, comprising 0.1% of its 13F portfolio. The second most bullish fund manager is Millennium Management, managed by Israel Englander, which holds a $23.6 million position; less than 0.1% of its 13F portfolio is allocated to the stock. Some other members of the smart money that hold long positions encompass Fred Cummings’s Elizabeth Park Capital Management, Paul Marshall and Ian Wace’s Marshall Wace LLP and Jim Simons’s Renaissance Technologies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!